Arkadios Wealth Advisors Purchases Shares of 1,911 Silicon Laboratories Inc. (NASDAQ:SLAB)

Arkadios Wealth Advisors acquired a new position in Silicon Laboratories Inc. (NASDAQ:SLAB) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,911 shares of the semiconductor company’s stock, valued at approximately $237,000.

A number of other hedge funds have also made changes to their positions in the business. Franklin Resources Inc. increased its holdings in Silicon Laboratories by 1.9% in the 3rd quarter. Franklin Resources Inc. now owns 231,889 shares of the semiconductor company’s stock valued at $27,001,000 after purchasing an additional 4,278 shares in the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of Silicon Laboratories in the third quarter worth about $7,408,000. Intech Investment Management LLC grew its stake in shares of Silicon Laboratories by 82.9% in the third quarter. Intech Investment Management LLC now owns 12,837 shares of the semiconductor company’s stock valued at $1,484,000 after buying an additional 5,818 shares in the last quarter. Barclays PLC raised its holdings in shares of Silicon Laboratories by 23.4% during the 3rd quarter. Barclays PLC now owns 70,568 shares of the semiconductor company’s stock valued at $8,157,000 after buying an additional 13,363 shares during the period. Finally, Clearbridge Investments LLC lifted its position in Silicon Laboratories by 84.0% during the 2nd quarter. Clearbridge Investments LLC now owns 273,776 shares of the semiconductor company’s stock worth $30,288,000 after acquiring an additional 125,022 shares in the last quarter.

Analysts Set New Price Targets

A number of research firms have recently issued reports on SLAB. StockNews.com upgraded shares of Silicon Laboratories to a “sell” rating in a research note on Friday, November 8th. Benchmark reiterated a “hold” rating on shares of Silicon Laboratories in a report on Tuesday, November 5th. Susquehanna started coverage on Silicon Laboratories in a research note on Tuesday, December 17th. They set a “neutral” rating and a $130.00 target price for the company. Barclays increased their price target on Silicon Laboratories from $75.00 to $120.00 and gave the company an “equal weight” rating in a report on Friday, January 17th. Finally, Morgan Stanley dropped their price objective on Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $133.56.

Silicon Laboratories Stock Up 1.1 %

Shares of NASDAQ:SLAB opened at $141.51 on Friday. The firm has a 50-day simple moving average of $122.62 and a 200 day simple moving average of $115.61. Silicon Laboratories Inc. has a fifty-two week low of $94.00 and a fifty-two week high of $154.91. The company has a market cap of $4.59 billion, a PE ratio of -19.12 and a beta of 1.17.

Silicon Laboratories (NASDAQ:SLAB) last announced its quarterly earnings results on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.07. Silicon Laboratories had a negative return on equity of 12.60% and a negative net margin of 46.93%. The business had revenue of $166.00 million for the quarter, compared to analysts’ expectations of $165.50 million. During the same period in the prior year, the firm earned $0.48 EPS. The business’s quarterly revenue was down 18.5% on a year-over-year basis. As a group, research analysts forecast that Silicon Laboratories Inc. will post -3.56 EPS for the current fiscal year.

Insider Activity

In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of Silicon Laboratories stock in a transaction that occurred on Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total value of $281,540.00. Following the transaction, the director now owns 32,115 shares in the company, valued at approximately $4,520,828.55. The trade was a 5.86 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.72% of the company’s stock.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.